In patients with vs without history of incident heart failure hospitalization there is more rapid decline in global cognition.

The Food and Drug Administration has approved Cobenfy (xanomeline and trospium chloride) for the treatment of adults with schizophrenia.

From 1999 to 2020, there was a decrease in menopausal hormone therapy (MHT) use among postmenopausal women, according to a study published online Sept. 27 in JAMA Health Forum. Lin Yang, Ph.D., from ...

As a surgical strategy for the management of glioblastoma, lobectomy improves overall survival and PFS by approximately 1 year, demonstrating its promise.

Treatment-resistant depression treatment responses were worse among older adults who had persistent insufficient sleep after 10 weeks.

Women with ADHD exhibited similar increases in basal activity and provoked activity levels as men with ADHD relative to patients without ADHD.

New opioid prescribing recommendations for acute pain management in children and adolescents in outpatient settings.

In a phase 3 trial, tolebrutinib has a significant effect on slowing disability progression in some patients with multiple sclerosis..

Hypertension-related stroke risk can be decreased by lowering systolic BP to less than 140 mm Hg via aggressive pharmacological treatment.

Sexual and gender-minority (SGM) persons have increased odds of adverse brain health outcomes, according to a study.

Reducing or preventing paramagnetic rim lesions (PRLs) could significantly slow multiple sclerosis (MS) progression.

Oral cladribine over a 2-year treatment period promotes remyelination in patients with highly active relapsing-remitting multiple sclerosis.